CDKN2A and melanoma: BRAFV600E induces melanoma in mice, where this can be accelerated by the absence of p16/INK4A or the PI3K-antagonist PTEN, or by UV exposure (Dankort et al., 2009; Dhomen et al., 2009; Viros et al., 2014).